|
Basic Characteristics of Mutations
|
|
Mutation Site
|
L776M |
|
Mutation Site Sentence
|
This is the first report of treatment of cytomegalovirus infection with artesunate, for a stem cell transplant recipient with a newly identified foscarnet-resistant and ganciclovir-resistant DNA polymerase L776M mutation. |
|
Mutation Level
|
Amino acid level |
|
Mutation Type
|
Nonsynonymous substitution |
|
Gene/Protein/Region
|
Pol |
|
Standardized Encoding Gene
|
UL54
|
|
Genotype/Subtype
|
- |
|
Viral Reference
|
-
|
|
Functional Impact and Mechanisms
|
|
Disease
|
Cytomegalovirus infections
|
|
Immune
|
- |
|
Target Gene
|
-
|
|
Clinical and Epidemiological Correlations
|
|
Clinical Information
|
Y |
|
Treatment
|
foscarnet;ganciclovir |
|
Location
|
- |
|
Literature Information
|
|
PMID
|
18419454
|
|
Title
|
Artesunate as a potent antiviral agent in a patient with late drug-resistant cytomegalovirus infection after hematopoietic stem cell transplantation
|
|
Author
|
Shapira MY,Resnick IB,Chou S,Neumann AU,Lurain NS,Stamminger T,Caplan O,Saleh N,Efferth T,Marschall M,Wolf DG
|
|
Journal
|
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
|
|
Journal Info
|
2008 May 1;46(9):1455-7
|
|
Abstract
|
This is the first report of treatment of cytomegalovirus infection with artesunate, for a stem cell transplant recipient with a newly identified foscarnet-resistant and ganciclovir-resistant DNA polymerase L776M mutation. Artesunate treatment resulted in a 1.7-2.1-log reduction in viral load by treatment day 7, with a viral half-life of 0.9-1.9 days, indicating a highly effective block in viral replication.
|
|
Sequence Data
|
-
|